FAK-Copy-Gain Is a Predictive Marker for Sensitivity to FAK Inhibition in Breast Cancer

Cancers - Switzerland
doi 10.3390/cancers11091288
Full Text
Abstract

Available in full text

Date
Authors
Publisher

MDPI AG

Related search

TIMP1 Is a Prognostic Marker for the Progression and Metastasis of Colon Cancer Through FAK-PI3K/AKT and MAPK Pathway

Journal of Experimental and Clinical Cancer Research
Cancer ResearchOncology
2016English

Direct Interaction of Focal Adhesion Kinase (FAK) With Met Is Required for FAK to Promote Hepatocyte Growth Factor-Induced Cell Invasion

Molecular and Cellular Biology
Cell BiologyMolecular Biology
2006English

An EGFR/Src-dependent Β4 Integrin/Fak Complex Contributes to Malignancy of Breast Cancer

Scientific Reports
Multidisciplinary
2015English

mTORC1 Inhibition Is Required for Sensitivity to PI3K P110 Inhibitors in PIK3CA-Mutant Breast Cancer

Science Translational Medicine
Medicine
2013English

RCP Induces FAK Phosphorylation and Ovarian Cancer Cell Invasion With Inhibition by Curcumin

Experimental & Molecular Medicine
2018English

Focal Adhesion Kinase (FAK) Activation by Estrogens Involves GPER in Triple-Negative Breast Cancer Cells

Journal of Experimental and Clinical Cancer Research
Cancer ResearchOncology
2019English

FAK Is a Critical Mediator of GNAQ-Driven Uveal Melanoma

Cancer Discovery
Oncology
2019English

Overexpression of Focal Adhesion Kinase in Head and Neck Squamous Cell Carcinoma Is Independent of Fak Gene Copy Number

Clinical Cancer Research
Cancer ResearchOncology
2006English

Localization of FAK Is Related With Colorectal Carcinogenesis

International Journal of Oncology
Cancer ResearchOncology
2008English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy